| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |